Anticomplement and the Indirect Antiglobulin Test
- 12 November 1979
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 19 (6) , 688-694
- https://doi.org/10.1046/j.1537-2995.1979.19680104094.x
Abstract
Ig[immunoglobulin]G complement-fixing [human] blood group alloantibodies, 140 of 17 different specificities, were used in tests to determine whether anticomplement antibodies were still necessary in antiglobulin reagents to be used in indirect antiglobulin tests. Anti-Rh and other IgG noncomplement fixing antibodies were excluded from the study. A polyspecific antiglobulin reagent that contained anti-IgG and anticomplement antibodies and an anti-IgG reagent containing the same level of anti-IgG as the polyspecific one, were compared. Titrations with some of the antibodies were repeated with only the polyspecific reagent. With each antibody, studies were done with complement activation blocked and compared with results in which it was allowed to proceed. Of the antibodies, 42.9% were detected at a higher dilution and 64.3% of them were detected with a higher titer score when the polyspecific antiglobulin serum containing anticomplement antibodies was used. Anticomplement antibodies were still essential for the correct performance of indirect antiglobulin tests.This publication has 8 references indexed in Scilit:
- Antiglobulin Sera—Past, Present and FutureTransfusion, 1978
- Hemolytic Transfusion Reactions Caused by Failure of Commercial Antiglobulin Reagents To Detect ComplementTransfusion, 1976
- The Significance of Red Cell Bound Complement Components in Development of Standards and Quality Assurance for the Anti‐Complement Components of Antiglobulin SeraTransfusion, 1976
- Immune Haemolytic Disease: The Autoimmune Haemolytic AnaemiasClinics in Haematology, 1975
- Evaluation of Commercial Antiglobulin Sera Over a Two‐Year Period. Part II. Anti‐IgG and Anti‐IgM Levels and Undesirable Contaminating AntibodiesTransfusion, 1974
- Evaluation of Commercial Antiglobulin Sera Over a Two‐ Year Period. Part I. Anti‐Beta 1A, Anti‐Alpha 2D, and Anti‐Beta IE LevelsTransfusion, 1974
- An Evaluation of Commercial Antiglobulin Sera with Particular Reference to Their Anticomplement PropertiesTransfusion, 1971
- Erythrocyte coating substances in patients with positive direct antiglobulin reactionsThe American Journal of Medicine, 1969